What is a dividend recapitalization?
It is a borrowing against the business, paid out to the owners as a distribution. Nothing is sold, no buyer is involved, and the owners keep every share they held. What changes is the balance sheet: the company carries new debt, and the owners hold cash they previously held as equity value.
The plainest way to describe it is that the owner has sold part of the business to its own balance sheet, at the cost of debt rather than at a multiple. Where a sale converts equity into cash at an exit valuation and ends the ownership, a recapitalization converts a slice of it at the interest rate, and the owner stays on the hook for the rest.
That is the entire trade, and it is a good one under a narrow set of conditions and an expensive one outside them. The conditions are not about the business. They are about the price of the alternative and the price of the debt, and both moved in 2026.
When does it beat running a sale?
When three things are true at once. The owner wants liquidity but not an exit. The sale market would clear the business below what the owner believes it is worth, or would not clear it at all. And the debt service on the new leverage is comfortably covered by cash flow the owner can forecast, not cash flow the owner is hoping for.
The second condition is doing most of the work at the moment. US private equity exits fell forty-six percent quarter on quarter to $102.6 billion in the second quarter of 2026, and within that, sponsor-to-sponsor sales fell fifty-seven percent by value to $24.5 billion with the count down thirty-eight percent to ninety-four, the lowest quarterly mark in at least a decade (PitchBook Q2 2026 US PE Breakdown, reported by PitchBook News, 6 July 2026). A seller planning a process around a second sponsor as the reliable underbidder is planning around a channel that has functionally switched off.
That is the argument for a recapitalization as a bridge. If the asset is good, the owner does not need to exit, and the market is not currently paying for quality it will pay for later, borrowing against the business and waiting is a rational alternative to accepting a bid struck in a thin market.
The third condition is the one that gets skipped. A recapitalization does not create cash flow. It creates a fixed claim on cash flow that already exists, and the coverage has to hold through whatever the next two years contain. Median interest coverage across the middle-market borrower population is 1.6 times, and the share of borrowers whose coverage was improving has plateaued after more than two years of gains (KBRA, Q2 2026 Middle Market Compendium, LTM ended 30 June 2026, published 28 July 2026). A business taking a dividend to the top of its capacity is joining a cohort with very little room.
What is the market actually doing?
Two different things at the two ends of the middle market, and the split is the most useful fact available. At the sponsored end, the activity contracted: sponsored recapitalization value fell to $10.2 billion in the first quarter of 2026 from $15.0 billion in the fourth quarter of 2025, and dividend recaps were expected to become more difficult or more expensive to execute moving into the third and fourth quarters (Capstone Partners, Q1 2026).
At the lower middle market end, the opposite. Recapitalization liquidity was described as being as robust as ever in the second quarter of 2026, with lender interest now reaching businesses below $10 million of trailing EBITDA, and the prohibitive premiums previously attached to non-accretive recapitalizations having in large part disappeared (SPP Capital Partners, Market At A Glance, July 2026). For an owner-operated business at that scale, the recapitalization market is more available now than it has been for some time.
The reason the two readings do not contradict each other is that they describe different lender populations chasing different problems. Capital aimed at sponsored credits is being consumed defending existing portfolios and is pricing new leverage for distributions accordingly. Capital aimed at the lower middle market is competing for a smaller pool of clean, founder-owned credits, and a recapitalization is one of the few ways to win one when the owner is not selling.
What is not ambiguous is the base rate. The Federal Reserve held at 3.50 to 3.75 percent on 29 July 2026 by a nine to three vote, with all three dissents in favour of a hike, the first time since September 2016 that three policymakers dissented in the same direction (FOMC statement, 29 July 2026). The forward curve prices three-month SOFR at 4.04 percent at the end of 2027 against 3.76 percent today (Blue Gamma, 4 August 2026). A floating-rate dividend taken today gets more expensive on the published forward path, not less.
“The question we ask is what the money is for. Diversification away from a single asset is a good reason and the arithmetic usually works. Funding a growth plan the business could have funded itself, or bridging to a price the market has already told you it will not pay, is borrowing to postpone a decision, and the coupon runs the whole time you are postponing it.”
What does the debt cost, and how much is available?
It depends almost entirely on size, and the spread between the bands is wider than most owners expect. At one-month term SOFR of 3.65 percent, senior non-bank and unitranche debt prices at SOFR plus 550 to 750 for a borrower below $10 million of EBITDA, an all-in cost of roughly 9.15 to 11.15 percent; at SOFR plus 500 to 650 between $10 million and $25 million; and at SOFR plus 425 to 575 above $25 million, an all-in of roughly 7.90 to 9.40 percent (SPP Capital Partners, July 2026; CME term SOFR, 4 August 2026).
Capacity moves the same way and has been tightening at the small end. Total debt to EBITDA clears at 2.50 to 3.25 times below $10 million of EBITDA, 4.00 to 5.50 times above $10 million and 5.00 to 6.50 times above $25 million. A year earlier the sub-$10 million band was 2.50 to 4.00 times, which is three-quarters of a turn of capacity lost in twelve months (SPP Capital Partners, July 2026).
The practical consequence is that the size of the dividend available to a smaller business is constrained twice: by a lower multiple of leverage and by a higher cost on each turn of it. Where a business needs to reach past senior capacity, junior capital for the same sub-$10 million cohort carries an all-in yield of 13 to 16 percent, up from 12 to 15 percent a year earlier (SPP Capital Partners, July 2026). A dividend funded from that tranche needs to be worth 13 to 16 percent a year to the owner who received it.
Nothing here forecasts where spreads go next. No named 2027 spread forecast exists for direct lending, and the furthest-forward published view reaches only the back half of 2026. What is published is the base rate path, and it points up.
| Trailing EBITDA | Senior non-bank spread | All-in at SOFR 3.65% | Total leverage available |
|---|---|---|---|
| Below $10m | SOFR + 550 to 750 | 9.15% to 11.15% | 2.50x to 3.25x |
| $10m to $25m | SOFR + 500 to 650 | 8.65% to 10.15% | 4.00x to 5.50x |
| Above $25m | SOFR + 425 to 575 | 7.90% to 9.40% | 5.00x to 6.50x |
| Below $10m, junior capital | Cash plus PIK | 13.00% to 16.00% | Above the senior band |
What does the transaction use up?
Debt capacity, covenant headroom, and the flexibility to respond to something unexpected. A recapitalization is not neutral to a future sale. It leaves the business more leveraged on the day a buyer runs its own model, which reduces the price a leveraged buyer can pay, and it leaves less room to fund an acquisition, a facility, or a bad year without another conversation with the same lender.
It also changes the character of the ownership. Before the transaction, a downturn costs the owner growth. Afterwards, a downturn costs the owner a covenant. Where the dividend is taken to the top of capacity, the owner has converted a flexible position into a fixed obligation at the exact moment the middle-market borrower population is showing coverage plateauing and earnings growth decelerating.
Against that, the case for doing it is real and should not be argued down. An owner whose entire net worth sits in one privately held business is running a concentration no adviser would recommend in any other asset, and the recapitalization is often the only instrument that reduces it without ending the ownership. Taking a portion of the value out and holding it outside the business is usually the single largest risk reduction available to a founder, and it does not require the business to be sold to a party the owner has not met.
The discipline that separates the good version from the bad one is the size of the dividend rather than the decision to take one. Sized to leave a full turn of headroom against the covenant and coverage that holds on a flat forecast, it is a diversification. Sized to the maximum a lender will fund, it is a bet on the next two years placed with borrowed money, and the current published record on rates gives no support to the assumption that refinancing rescues it.
As of August 2026
Sources: SPP Capital Partners, Market At A Glance, July 2026, for senior non-bank and unitranche spreads and total leverage by EBITDA band, for the July 2025 comparatives showing three-quarters of a turn of capacity lost below $10 million of EBITDA, for junior capital at 13% to 16% all-in against 12% to 15% a year earlier, and for lower-middle-market recapitalization liquidity remaining robust in Q2 2026 with lender interest reaching below $10 million of trailing EBITDA and prohibitive premiums on non-accretive recapitalizations having largely disappeared; Capstone Partners, Q1 2026, for sponsored recapitalization value of $10.2 billion in Q1 2026 against $15.0 billion in Q4 2025 and for the expectation that dividend recaps become more difficult or expensive into Q3 and Q4 2026; PitchBook Q2 2026 US PE Breakdown, reported by PitchBook News, 6 July 2026, for US private equity exits of $102.6 billion, down 46% quarter on quarter, and for sponsor-to-sponsor sales down 57% by value to $24.5 billion with the count down 38% to 94, the lowest quarterly mark in at least a decade; KBRA, Q2 2026 Middle Market Compendium, LTM ended 30 June 2026, published 28 July 2026, for median interest coverage of 1.6 times and for the plateau in the share of borrowers with improving coverage; Federal Open Market Committee statement, 29 July 2026, for the hold at 3.50% to 3.75% on a nine to three vote with three dissents in favour of a hike, the first time since September 2016 that three policymakers dissented in the same direction; CME term SOFR as at 4 August 2026 for the 3.65% one-month and 3.76% three-month rates, and Blue Gamma, 4 August 2026, for the three-month SOFR forward curve at 4.04% at end-2027. No forward spread forecast is printed: no named 2027 direct lending spread forecast exists as at August 2026. Companion articles on this site cover how much a business can borrow, and how coverage rather than leverage decides a financing.

